CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Study of Intravenous (IV) Palifosfamide-tris Administered in Combination With IV Etoposide and IV Carboplatin in Patients With Malignancies for Which Etoposide and Carboplatin Are an Appropriate Choice

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01242072
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:17.644582+00:00
Published At: 2012-07-18T00:00:00+00:00
Record Updated At: 2012-07-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Malignancy", "Cancer", "Non Small Cell Lung Cancer", "Small Cell Lung Cancer", "Testicular Cancer", "Thymoma", "Ovarian Cancer", "Osteosarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2012-07-18"
protocolSection.identificationModule.nctId: "NCT01242072"
protocolSection.identificationModule.officialTitle: "A Phase I Study of Intravenous (IV) Palifosfamide-tris Administered in Combination With IV Etoposide and IV Carboplatin in Patients With Malignancies for Which Etoposide and Carboplatin Are an Appropriate Choice"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.